Literature DB >> 15131551

Lipid profile of patients with aortic stenosis might be predictive of rate of progression.

Mehmet Birhan Yilmaz1, Umit Guray, Yesim Guray, Gokhan Cihan, Vedat Caldir, Serkan Cay, Halil L Kisacik, Sule Korkmaz.   

Abstract

BACKGROUND: Aortic stenosis is one of the most commonly encountered valvular pathology requiring surgery in developed countries. There are similarities between risk factors for coronary atherosclerosis and the development of aortic stenosis. We designed a retrospective study, evaluated the lipid profile and previous echocardiographic recordings of patients with aortic stenosis, and searched the association of rate of progression and lipid profile. METHODS AND
RESULTS: The annual rates of progression in the peak and mean aortic gradients were 8.5 +/- 3.2 and 6.7 +/- 2.2 mm Hg/year, respectively. We classified the annual rate of progression of peak aortic gradient into 2 groups, group 1 with <10 mm Hg ("slow progressors") and group 2 with > or =10 mm Hg annual rate of progression ("fast progressors"). The annual rate of progression in group 1 was significantly higher than that in group 2, both in peak and mean aortic gradients (12 +/- 2 mm Hg and 6.4 +/- 1.6 mm Hg; 9 +/- 1.3 mm Hg and 5.2 +/- 1.1 mmHg; P <.001 for both). There was a highly significant difference between group 1 and group 2 for total cholesterol/high-density lipoprotein (HDL) cholesterol level ratio (7.1 +/- 1.4 vs 5.2 +/- 1.3, P <.001). There was a significant correlation between annual rate of progression in peak gradient and total cholesterol/HDL cholesterol level ratio (r = 0.399, P =.009). Smoking (P =.024, Beta = 0.26), presence of coronary heart disease (P =.011, Beta = 0.31), and total cholesterol/HDL cholesterol level ratio (P =.004, Beta = 1.98) were independently predictive of fast progression of the peak aortic gradient in the regression analysis.
CONCLUSION: In a small group of patients from Turkey with aortic stenosis, there seems to be an association between the rate of progression and total cholesterol/HDL cholesterol level ratio, with fast progression occurring in the group with higher ratios.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131551     DOI: 10.1016/j.ahj.2003.11.011

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

1.  Risk factors for progression of calcific aortic stenosis and potential therapeutic targets.

Authors:  Ashvin R Kamath; Ramdas G Pai
Journal:  Int J Angiol       Date:  2008

Review 2.  When is concomitant aortic valve replacement indicated in patients with mild to moderate stenosis undergoing coronary revascularization?

Authors:  A Marc Gillinov; Mario J Garcia
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

3.  Importance of serum high-density lipoprotein levels to aortic valvular disease.

Authors:  O C Yontar; M B Yilmaz
Journal:  Br J Pharmacol       Date:  2008-09-01       Impact factor: 8.739

4.  Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits.

Authors:  D Busseuil; Y Shi; M Mecteau; G Brand; A-E Kernaleguen; E Thorin; J-G Latour; E Rhéaume; J-C Tardif
Journal:  Br J Pharmacol       Date:  2008-04-14       Impact factor: 8.739

Review 5.  Mechanisms of aortic valve calcification: the LDL-density-radius theory: a translation from cell signaling to physiology.

Authors:  Nalini M Rajamannan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-23       Impact factor: 4.733

6.  Role of serum high density lipoprotein levels and functions in calcific aortic valve stenosis progression.

Authors:  Hilal Olgun Küçük; Uğur Küçük; Canan Demirtaş; Murat Özdemir
Journal:  Int J Clin Exp Med       Date:  2015-12-15

7.  ApoB/ApoA-I Ratio is Associated With Faster Hemodynamic Progression of Aortic Stenosis: Results From the PROGRESSA (Metabolic Determinants of the Progression of Aortic Stenosis) Study.

Authors:  Lionel Tastet; Romain Capoulade; Mylène Shen; Marie-Annick Clavel; Nancy Côté; Patrick Mathieu; Marie Arsenault; Élisabeth Bédard; Alexe Tremblay; Marilie Samson; Yohan Bossé; Jean G Dumesnil; Benoit J Arsenault; Jonathan Beaudoin; Mathieu Bernier; Jean-Pierre Després; Philippe Pibarot
Journal:  J Am Heart Assoc       Date:  2018-02-10       Impact factor: 5.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.